文献速递腹部技术与安全CT

人工智能在胃癌中的应用:机器学习与深度学习应用的系统综述

Artificial intelligence in gastric cancer: a systematic review of machine learning and deep learning applications.
PubMed 文献 · Abdom Radiol (NY) · 2025-09-11

该研究遵循PRISMA 2020指南,检索MEDLINE、Web of Science和Scopus数据库(2004年至2025年5月),纳入59项应用机器学习或深度学习进行胃癌诊断或预后任务的研究。深度学习模型在早期胃癌检测中敏感度高达95.3%、AUC高达0.981,CT影像组学与深度学习模型用于肿瘤分期和转移预测的AUC为0.825至0.972。主要挑战包括算法偏倚、数据集多样性有限、可解释性问题和临床整合障碍。

要点

  • 深度学习模型检测早期胃癌敏感度最高达95.3%,AUC最高达0.981,常超过专家内镜医师。
  • 基于CT的影像组学和深度学习模型用于肿瘤分期和转移预测,AUC范围为0.825至0.972。
  • 基于病理的模型检测早期胃癌准确率最高达100%,预测治疗反应的AUC最高达0.92。

核心结论

  • 机器学习与深度学习模型在改善胃癌早期检测、诊断准确性和个体化治疗方面显示出巨大潜力。

研究设计与样本

  • 系统综述,遵循PRISMA 2020指南,检索MEDLINE、Web of Science和Scopus数据库2004年至2025年5月发表的文献,最终纳入59项研究,由两名评价者独立完成研究筛选、数据提取和偏倚风险评估。

诊断标准与关键数值

  • 深度学习模型(尤其是卷积神经网络)检测早期胃癌的敏感度高达95.3%,AUC高达0.981。
  • 基于CT的影像组学和深度学习模型用于肿瘤分期和转移预测的AUC为0.825至0.972。
  • 基于病理的模型检测早期胃癌的准确率高达100%,预测治疗反应的AUC高达0.92。
  • 结合影像组学和病理组学的跨模态方法AUC高达0.951。

局限性

  • 关键挑战包括算法偏倚、数据集多样性有限、可解释性问题和临床整合障碍。
  • 未来研究应优先开发大型、多样化数据集,实施可解释的人工智能框架,并开展前瞻性临床试验。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Gastric cancer (GC) remains a major global health concern, ranking as the fifth most prevalent malignancy and the fourth leading cause of cancer-related mortality worldwide. Although early detection can increase the 5-year survival rate of early gastric cancer (EGC) to over 90%, more than 80% of cases are diagnosed at advanced stages due to subtle clinical symptoms and diagnostic challenges. Artificial intelligence (AI), particularly machine learning (ML) and deep learning (DL), has shown great promise in addressing these limitations.

OBJECTIVES: This systematic review aims to evaluate the performance, applications, and limitations of ML and DL models in GC management, with a focus on their use in detection, diagnosis, treatment planning, and prognosis prediction across diverse clinical imaging and data modalities.

METHODS: Following the PRISMA 2020 guidelines, a comprehensive literature search was conducted in MEDLINE, Web of Science, and Scopus for studies published between 2004 and May 2025. Eligible studies applied ML or DL algorithms for diagnostic or prognostic tasks in GC using data from endoscopy, computed tomography (CT), pathology, or multi-modal sources. Two reviewers independently performed study selection, data extraction, and risk of bias assessment.

RESULTS: A total of 59 studies met the inclusion criteria. DL models, particularly convolutional neural networks (CNNs), demonstrated strong performance in EGC detection, with reported sensitivities up to 95.3% and Area Under the Curve (AUCs) as high as 0.981, often exceeding expert endoscopists. CT-based radiomics and DL models achieved AUCs ranging from 0.825 to 0.972 for tumor staging and metastasis prediction. Pathology-based models reported accuracies up to 100% for EGC detection and AUCs up to 0.92 for predicting treatment response. Cross-modality approaches combining radiomics and pathomics achieved AUCs up to 0.951. Key challenges included algorithmic bias, limited dataset diversity, interpretability issues, and barriers to clinical integration.

CONCLUSION: ML and DL models have demonstrated substantial potential to improve early detection, diagnostic accuracy, and individualized treatment in GC. To advance clinical adoption, future research should prioritize the development of large, diverse datasets, implement explainable AI frameworks, and conduct prospective clinical trials. These efforts will be essential for integrating AI into precision oncology and addressing the increasing global burden of gastric cancer.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Alsallal M, Habeeb MS, Vaghela K, et al. Artificial intelligence in gastric cancer: a systematic review of machine learning and deep learning applications. Abdom Radiol (NY). 2025. PMID: 40932499. doi:10.1007/s00261-025-05181-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。